Advisortrust Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$831K Sell
3,176
-1,122
-26% -$288K 0.26% 73
2026
Q2
$1.08M Buy
4,298
+1,445
+51% +$311K 0.37% 49
2026
Q1
$620K Sell
2,853
-32
-1% -$7.1K 0.26% 60
2025
Q4
$659K Buy
+2,885
New +$657K 0.29% 53

Other funds holding ABBV

Advisortrust Partners's ABBV Position: Q3 2026 in Review

Advisortrust Partners reduced its AbbVie (ABBV) stake by 26% in Q3 2026, selling an estimated $288K and leaving 3,176 shares worth $831K. The position accounts for 0.26% of the portfolio, ranked #73.

Advisortrust Partners first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.08M in Q2 2026. 4,279 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Advisortrust Partners held 3,176 shares of AbbVie worth $831K as of Q3 2026.
  • Advisortrust Partners sold 1,122 AbbVie shares in Q3 2026, an estimated $288K.
  • AbbVie made up 0.26% of Advisortrust Partners's portfolio in Q3 2026, its #73 holding.
  • Advisortrust Partners first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • Advisortrust Partners's AbbVie position peaked at $1.08M in Q2 2026.
  • 4,279 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Advisortrust Partners's 13F filing for Q3 2026, filed 2 Nov 2026.